High Throughput News and Research

RSS

New biomaterial from Rutgers

A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials (NJCBM) at Rutgers University, has moved from the lab bench to field testing in record time.

19 Oct 2007

Phase II map of human genetic variation

The International HapMap Consortium today published analyses of its second-generation map of human genetic variation, which contains three times more markers than the initial version unveiled in 2005.

18 Oct 2007

New knowledge about basic cancer biology

Merging technological innovations and new knowledge about basic cancer biology, cancer researchers now target specific molecules involved in critical chemical pathways of cancerous cells.

17 Oct 2007

Direct selection of human genomic loci by microarray hybridization

Researchers at Baylor College of Medicine and Roche NimbleGen Inc., a fully integrated part of Roche Applied Science, have published details of a highly efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip microarrays in preparation for high-throughput 454 Sequencing.

16 Oct 2007

Brookhaven's D-peptides halt HIV entry into cells

Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class.

10 Oct 2007

New peptides inhibit HIV's entry into cells

9 Oct 2007

Extremely sensitive future screening technology

After the plot to blow up trans-Atlantic airlines with liquid explosives was uncovered in London in August 2006, there has been pressure on the airline industry, and Homeland Security, to find new ways to not only detect liquids in baggage and on airline passengers, but also to figure out what they are.

3 Oct 2007

Cancer researchers seek safe reduction of radiotherapy

Around half of patients receive radiotherapy as part of their cancer treatment but the dose is limited by the possibility of causing side effects (toxicity) to the normal tissues and organs that surround the tumour.

From The University of Manchester 3 Oct 2007

Cancer researchers seek safe reduction of radiotherapy

University of Manchester scientists discussed their research aimed at reducing the side effects of radiotherapy without decreasing its effectiveness at the National Cancer Research Institute conference in Birmingham today (Tuesday 2 October 2007).

From The University of Manchester 2 Oct 2007

New view of what causes greatest genetic variability among individuals

A study by Yale researchers offers a new view of what causes the greatest genetic variability among individuals - suggesting that it is due less to single point mutations than to the presence of structural changes that cause extended segments of the human genome to be missing, rearranged, or present in extra copies.

27 Sep 2007

New partnership offers outsourced research and development in membrane biology

One of the UK's most successful academic entrepreneurs has teamed up with the University of Leeds to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies.

25 Sep 2007

When biological molecules kiss, a new kind of biosensor can tell

A new and deceptively simple technique has been developed by chemists at Vanderbilt University that can measure the interactions between free-floating, unlabeled biological molecules including proteins, sugars, antibodies, DNA and RNA.

21 Sep 2007

Cell growth technology promises more successful drug development

Scientists have developed unique technology to grow stem cells and other tissue in the laboratory in conditions similar to the way they grow in the human body.

20 Sep 2007

New Rensselaer tools speed stem cell research

Engineers at Rensselaer Polytechnic Institute have developed tools to help solve two of the main problems slowing the progress of stem cell research - how to quickly test stem cell response to different drugs or genes, and how to create a large supply of healthy, viable stem cells to study from only a few available cells.

13 Sep 2007

Novel enzyme may offer huge range of potential therapeutic agents

By guiding an enzyme down a new evolutionary pathway, a team of University of Wisconsin-Madison researchers has created a new form of an enzyme capable of producing a range of potential new therapeutic agents with anticancer and antibiotic properties.

10 Sep 2007

First individual genome sequence of one person

Independent sequence and assembly of the six billion base pairs from the genome of one person ushers in the era of individualized genomics

4 Sep 2007

Novel approach used to uncover genetic components of aging

People who live to 100 or more are known to have just as many - and sometimes even more - harmful gene variants compared with younger people.

26 Aug 2007

Nanoscale dots target and track apoptosis

Apoptosis, or programmed cell death, is a hallmark effect triggered by effective anticancer drugs. Now, researchers in Korea have developed a biocompatible, fluorescent nanoparticle that could provide an early sign that apoptosis is occurring as a result of anticancer therapy.

23 Jul 2007

Curing canine cancer - human cancer benefit

One of the major issues associated with longer life expectancy in man and his best friend is an increase in the incidence of cancer.

13 Jul 2007

Chromosome linked to colorectal cancer identified

Researchers at the Ontario Institute for Cancer Research and Cancer Care Ontario have successfully identified a specific genetic variation on chromosome 8 that is associated with colorectal cancer.

9 Jul 2007